BR9714641A - Mutantes de toxina a de estreptococo e métodos de uso - Google Patents

Mutantes de toxina a de estreptococo e métodos de uso

Info

Publication number
BR9714641A
BR9714641A BR9714641-2A BR9714641A BR9714641A BR 9714641 A BR9714641 A BR 9714641A BR 9714641 A BR9714641 A BR 9714641A BR 9714641 A BR9714641 A BR 9714641A
Authority
BR
Brazil
Prior art keywords
toxin
methods
spe
mutants
vaccine
Prior art date
Application number
BR9714641-2A
Other languages
English (en)
Inventor
Patrick M Schlievert
Manuela Roggiani
Jennifer Stoehr
Douglas Ohlendorf
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of BR9714641A publication Critical patent/BR9714641A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MUTANTES DE TOXINA A DE ESTREPTOCOCO E MéTODOS DE USO". A presente invenção refere-se a toxina SPE-A mutantes ou seus fragmentos, vacina e composições farmacêuticas e métodos de uso da vacina e das composições farmacêuticas. A toxina SPE-A preferida tem pelo menos uma mudança de aminoácido e é substancialmente não letal em comparação com a toxina SPE-A do tipo selvagem. As toxinas SPE-A mutantes podem formar composições de vacina úteis para proteger animais das atividades biológicas da toxina SPE-A do tipo selvagem.
BR9714641-2A 1996-12-06 1997-12-05 Mutantes de toxina a de estreptococo e métodos de uso BR9714641A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3293096P 1996-12-06 1996-12-06
PCT/US1997/022228 WO1998024911A2 (en) 1996-12-06 1997-12-05 Mutants of streptococcal toxin a and methods of use

Publications (1)

Publication Number Publication Date
BR9714641A true BR9714641A (pt) 2002-01-22

Family

ID=21867628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714641-2A BR9714641A (pt) 1996-12-06 1997-12-05 Mutantes de toxina a de estreptococo e métodos de uso

Country Status (11)

Country Link
US (2) US6913755B2 (pt)
EP (1) EP0948624B1 (pt)
JP (1) JP2001505439A (pt)
KR (1) KR100548663B1 (pt)
CN (1) CN1211487C (pt)
AT (1) ATE346860T1 (pt)
AU (1) AU7625798A (pt)
BR (1) BR9714641A (pt)
CA (1) CA2273822A1 (pt)
DE (1) DE69737032D1 (pt)
WO (1) WO1998024911A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
WO1998024911A2 (en) * 1996-12-06 1998-06-11 Regents Of The University Of Minnesota Mutants of streptococcal toxin a and methods of use
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
US20040236082A1 (en) * 2001-04-13 2004-11-25 Marshall Matthew J. Modified staphylococcal enterotoxins and expression systems therefore
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
EP2083016B1 (en) * 2001-11-26 2011-06-15 U.S. Medical Research Institute of Infectious Diseases Bacterial superantigen vaccines
RU2472772C2 (ru) * 2007-03-01 2013-01-20 Басф Се Способ получения триэтилентетрамина (тэта) через этилендиаминдиацетонитрил (эддн)
EP3411409A2 (en) 2016-01-10 2018-12-12 Neotx Therapeutics Ltd. Immunopotentiator enhanced superantigen mediated cancer immunotherapy
WO2019218022A1 (en) * 2018-05-16 2019-11-21 Griffith University Streptococcal toxic shock syndrome
CN114025791A (zh) 2019-05-15 2022-02-08 尼奥克斯医疗有限公司 癌症治疗
CN115484978A (zh) 2020-03-05 2022-12-16 尼奥克斯医疗有限公司 使用免疫细胞治疗癌症的方法和组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172126A (en) * 1976-11-08 1979-10-23 Sankyo Company Limited Method for the inactivation of microbial toxins and attenuation of vaccines
US4784948A (en) 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5336598A (en) 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
US5298396A (en) 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
WO1993014634A1 (en) 1992-01-28 1993-08-05 National Jewish Center For Immunology And Respiratory Medicine Protective effects of mutated superantigens
US6632441B2 (en) * 1995-06-07 2003-10-14 Regents Of The University Of Minnesota Mutants of streptococcal toxin a and methods of use
WO1998024911A2 (en) * 1996-12-06 1998-06-11 Regents Of The University Of Minnesota Mutants of streptococcal toxin a and methods of use

Also Published As

Publication number Publication date
ATE346860T1 (de) 2006-12-15
AU7625798A (en) 1998-06-29
WO1998024911A2 (en) 1998-06-11
EP0948624A2 (en) 1999-10-13
CA2273822A1 (en) 1998-06-11
US6913755B2 (en) 2005-07-05
WO1998024911A3 (en) 1998-08-20
CN1211487C (zh) 2005-07-20
DE69737032D1 (de) 2007-01-11
US20060041107A1 (en) 2006-02-23
KR100548663B1 (ko) 2006-02-03
CN1246151A (zh) 2000-03-01
US20020086813A1 (en) 2002-07-04
EP0948624B1 (en) 2006-11-29
KR20000069316A (ko) 2000-11-25
JP2001505439A (ja) 2001-04-24

Similar Documents

Publication Publication Date Title
BR9714641A (pt) Mutantes de toxina a de estreptococo e métodos de uso
PT832241E (pt) Mutantes de toxina a estreptococica e metodos de utilizacao
BR9713679A (pt) Mutantes de toxina c de estreptococo e métodos de uso
BR9508633A (pt) Composição preparação de vacina estojo e processos para criar ou sustentar uma resposta imune protetora ou adaptadora a um antígeno em um hospedeiro e para induzir uma resposta imune protetora contra um organismo bacteriano enterotóxico
HUP9801240A2 (en) Oral compositions
TR200901109T1 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
BR9610872A (pt) Proteìna receptora de transferrina de moraxella
DK0816378T3 (da) Antibiotiske glycopeptidamidderivater
IE860089L (en) Spergualin compositions
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE287963T1 (de) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
DE3667469D1 (de) Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung.
BR0014740A (pt) Lantibiótico
NZ503463A (en) Leukotoxin deletion mutant of Pasteurella haemolytica
ATE173608T1 (de) Präparat gegen haarausfall und brüchiche nägel
ATE356831T1 (de) Neuer galaninrezeptor
DE68914397D1 (de) Menschliches Lymphotoxin.
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
SE9604439D0 (sv) New receptor
BR0007255A (pt) Derivados carbamato de diaril 1,3,4-oxadiazolona
BR9809405A (pt) Proteinase de streptococcus pneumoniae que degrada complemento humano c3
IT1276454B1 (it) Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico.
AU3569995A (en) Muramyl peptide compositions for inhibiting hiv replication
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI